Global News

Cubist to acquire Optimer, Trius

Wednesday, July 31, 2013 11:43 AM

Cubist Pharmaceuticals has signed agreements to acquire both Optimer Pharmaceuticals and Trius Therapeutics. Both transactions have been approved by company boards of directors and are expected to close later this year, subject to stockholder approval.

More... »

Retroscreen Virology purchases ALPHADAS

Wednesday, July 31, 2013 11:43 AM

Retroscreen Virology Group, a virology healthcare company, has purchased the ALPHADAS clinical trials software suite to accelerate and reduce the cost of bringing anti-viral drugs, diagnostics and vaccines to market.

More... »

Covance: Survey of investigators rates it first in central lab services

Tuesday, July 30, 2013 01:44 PM

CRO Covance said its central laboratory services once again ranked first in an independent global survey of physician investigators in clinical trials. Of the study participants, 47% named Covance’s central lab services as their "most preferred" central lab, with investigators citing Covance more than twice as often as the nearest competitor.  Investigators also reported having the "best overall relationship" with Covance, rating it 8.4 on a scale of 1 to 10.

More... »

InspireMD announces first patient enrolled in MGuard trial

Tuesday, July 30, 2013 10:30 AM

InspireMD, an embolic protection stents company, has enrolled its first patient in the Master II IDE clinical trial to evaluate the safety and effectiveness of the MGuard Prime Embolic Protection Stent (EPS) in patients suffering from ST Elevation Myocardial Infarction (STEMI).

More... »

Crown Bioscience acquires PRECOS

Tuesday, July 30, 2013 09:45 AM

Crown Bioscience of Santa Clara, Calif., a global drug discovery and development service company, has acquired the shares of U.K.-based Preclinical Oncology Services Limited (PRECOS), a preclinical R&D service provider with a specific focus on oncology.

More... »

Pfizer to create separate internal, global innovative and value businesses

Monday, July 29, 2013 03:00 PM

Pfizer has announced plans to internally separate its commercial operations into three business segments, two of which will include innovative business lines and a third to include the value business line. 

More... »

PSI expands South African clinical trial presence

Monday, July 29, 2013 01:29 PM

Switzerland-based CRO PSI has expanded into South Africa and will expand its access to all African countries from its base in Pretoria. PSI's experience in South Africa includes oncology, CNS, urology and diabetes.

More... »

AstraZeneca selects Dotmatics platform

Monday, July 29, 2013 01:25 PM

AstraZeneca’s Neuroscience Innovative Medicines Unit (iMed) has selected Dotmatics’ cloud based informatics platform as its research data management solution. The Dotmatics platform provides a single point of access to all data and functions across multidisciplinary groups. The platform includes compound registration and tracking, biological screening, DMPK analysis, fully integrated chemistry and biology ELN and project management to enable scientists, collaborators and partners to instantly interact with the same data regardless of location and time zone.

More... »

Perrigo to acquire Elan for $8.6 billion

Monday, July 29, 2013 11:02 AM

Allegan, Mich.-based Perrigo, a global provider of healthcare products and Elan, a Dublin-based biotechnology company, have entered into a definitive agreement under which Elan will be acquired by a new holding company incorporated in Ireland (“New Perrigo”).

More... »

Gentris names Amelia Wall president

Friday, July 26, 2013 03:12 PM

Gentris, a pharmacogenomics and biorepository solutions company, has named Dr. Amelia Wall Warner its new president. Warner will oversee U.S. operations, lead the development of new service offerings and develop scientific education and training programs for biobanking and pharmacogenomics.

More... »